MedPath

NOVELLI ENRICO

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

2 Phases

Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 1
1 (50.0%)

Cutaneous Hydration Assessment in SCD

Not Applicable
Recruiting
Conditions
Sickle Cell Disease
First Posted Date
2022-01-27
Last Posted Date
2024-11-12
Lead Sponsor
Enrico Novelli
Target Recruit Count
30
Registration Number
NCT05210114
Locations
🇺🇸

UPMC Sickle Cell Clinic, Pittsburgh, Pennsylvania, United States

PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD

Phase 1
Recruiting
Conditions
Sickle Cell Disease
Interventions
Radiation: Positron Emission Tomography
Drug: Cu-64]-LLP2A
First Posted Date
2021-06-14
Last Posted Date
2025-05-07
Lead Sponsor
Enrico Novelli
Target Recruit Count
20
Registration Number
NCT04925492
Locations
🇺🇸

UPMC, Pittsburgh, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.